MedPath

A study of blood sugar reducing effect of Homoeopathic Drug Phosphoricum Acidum 6C under laboratory setting with clinical evaluation of the same in Type 2 Diabetes Mellitus

Phase 3
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2023/11/059774
Lead Sponsor
Dr Vineeth S Nair
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Fasting blood glucose concentration greater than or equal to 135mg/dl

2.Patients those who are willing to give written consent to participate in the study

Exclusion Criteria

1.Cases with other serious illness like carcinomas or severely immune compromised.

2. Chronic smokers and chronic alcoholics.

3. Patients under insulin therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) In Vitro Study (in hyperglycemic blood serum) <br/ ><br>Title: Reduction in the fasting serum glucose concentration. <br/ ><br>Description: Glucose Baseline Value - Final Concentration of Glucose <br/ ><br>Interval: 2 hours. <br/ ><br>2) Clinical study <br/ ><br>Title: Reduction in the fasting serum glucose concentration. <br/ ><br>Description: Glucose baseline value – Final glucose concentration. <br/ ><br>Interval: 2 months.Timepoint: After medicinal prescription according to <br/ ><br>homoeopathic principle mean glucose estimation will be repeated <br/ ><br>after one week and added 4 weeks of treatment. Obtained values will be taken for <br/ ><br>analysis.
Secondary Outcome Measures
NameTimeMethod
Comparison of Therapeutic effectiveness of Phosphoricum Acidum & Syzygium Jambolanum among the groupTimepoint: After 1 Year (after completion of the study)
© Copyright 2025. All Rights Reserved by MedPath